{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:53:26Z","timestamp":1788386006446,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10067-024-07138-5","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T09:24:58Z","timestamp":1726651498000},"page":"3361-3372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Systematic analysis of serum peptidase inhibitor 3 in psoriasis diagnosis and treatment"],"prefix":"10.1007","volume":"43","author":[{"given":"Meng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhining","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2352-9866","authenticated-orcid":false,"given":"Xiaobo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanjian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"7138_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","volume":"7","author":"GK Perera","year":"2012","unstructured":"Perera GK, Di Meglio P, Nestle FO (2012) Psoriasis. Annu Rev Pathol 7:385\u2013422","journal-title":"Annu Rev Pathol"},{"issue":"16","key":"7138_CR2","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.3390\/ijms21165617","volume":"21","author":"D Holmannova","year":"2020","unstructured":"Holmannova D, Borsky P, Borska L et al (2020) Metabolic syndrome, clusterin and elafin in patients with psoriasis vulgaris. Int J Mol Sci 21(16):5617","journal-title":"Int J Mol Sci"},{"key":"7138_CR3","doi-asserted-by":"crossref","unstructured":"Ben Salem C, Hmouda H, Bouraoui K (2009) Psoriasis. N Engl J Med 361,1710; author reply 1710","DOI":"10.1056\/NEJMc091749"},{"key":"7138_CR4","doi-asserted-by":"crossref","unstructured":"Kanda N (2021) Psoriasis: pathogenesis, comorbidities, and therapy updated. Int J Mol Sci 22","DOI":"10.3390\/ijms22062979"},{"key":"7138_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2012.26","volume":"2","author":"AW Armstrong","year":"2012","unstructured":"Armstrong AW, Harskamp CT, Armstrong EJ (2012) The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies. Nutr Diabetes 2:e54","journal-title":"Nutr Diabetes"},{"key":"7138_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1346-8138.2009.00777.x","volume":"37","author":"N Al-Mutairi","year":"2010","unstructured":"Al-Mutairi N, Al-Farag S, Al-Mutairi A et al (2010) Comorbidities associated with psoriasis: an experience from the Middle East. J Dermatol 37:146\u2013155","journal-title":"J Dermatol"},{"key":"7138_CR7","doi-asserted-by":"crossref","unstructured":"Karas A, Holmannova D, Borsky P et al. (2022) Significantly altered serum levels of NAD, AGE, RAGE, CRP, and elastin as potential biomarkers of psoriasis and aging-a case-control study. Biomedicines 10","DOI":"10.3390\/biomedicines10051133"},{"key":"7138_CR8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/rheumatology\/keaa405","volume":"60","author":"E Leijten","year":"2021","unstructured":"Leijten E, Tao W, Pouw J et al (2021) Broad proteomic screen reveals shared serum proteomic signature in patients with psoriatic arthritis and psoriasis without arthritis. Rheumatology (Oxford) 60:751\u2013761","journal-title":"Rheumatology (Oxford)"},{"key":"7138_CR9","first-page":"10","volume":"2019","author":"A Berekm\u00e9ri","year":"1931","unstructured":"Berekm\u00e9ri A, Tiganescu A, Alase AA et al (1931) Non-invasive approaches for the diagnosis of autoimmune\/autoinflammatory skin diseases-a focus on psoriasis and lupus erythematosus. Front Immunol 2019:10","journal-title":"Front Immunol"},{"key":"7138_CR10","doi-asserted-by":"crossref","unstructured":"Feldman SR, Krueger GG (2005) Psoriasis assessment tools in clinical trials. Ann Rheum Dis 64 Suppl 2, ii65\u201368; discussion ii69\u201373","DOI":"10.1136\/ard.2004.031237"},{"key":"7138_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/ijd.14217","volume":"58","author":"I Elgharib","year":"2019","unstructured":"Elgharib I, Khashaba SA, Elsaid HH et al (2019) Serum elafin as a potential inflammatory marker in psoriasis. Int J Dermatol 58:205\u2013209","journal-title":"Int J Dermatol"},{"key":"7138_CR12","doi-asserted-by":"crossref","unstructured":"Villanova F, Di Meglio P, Nestle FO (2013) Biomarkers in psoriasis and psoriatic arthritis. Ann Rheum Dis 72 Suppl 2, ii104\u2013110","DOI":"10.1136\/annrheumdis-2012-203037"},{"key":"7138_CR13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.gpb.2015.04.002","volume":"13","author":"S Jiang","year":"2015","unstructured":"Jiang S, Hinchliffe TE, Wu T (2015) Biomarkers of an autoimmune skin disease\u2013psoriasis. Genomics Proteomics Bioinformatics 13:224\u2013233","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"7138_CR14","doi-asserted-by":"publisher","first-page":"7361826","DOI":"10.1155\/2019\/7361826","volume":"2019","author":"D Wang","year":"2019","unstructured":"Wang D, Fang L, Pan G (2019) Association of Serum Lipocalin-2 Concentrations with psoriasis and psoriatic arthritis: an updated meta-analysis. Dis Markers 2019:7361826","journal-title":"Dis Markers"},{"key":"7138_CR15","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3389\/fphar.2020.01238","volume":"11","author":"M Forouzandeh","year":"2020","unstructured":"Forouzandeh M, Besen J, Keane RW et al (2020) The inflammasome signaling proteins ASC and IL-18 as biomarkers of psoriasis. Front Pharmacol 11:1238","journal-title":"Front Pharmacol"},{"key":"7138_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/bjd.12355","volume":"169","author":"EA Dowlatshahi","year":"2013","unstructured":"Dowlatshahi EA, van der Voort EA, Arends LR et al (2013) Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis. Br J Dermatol 169:266\u2013282","journal-title":"Br J Dermatol"},{"key":"7138_CR17","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/exd.13727","volume":"27","author":"X Hong","year":"2018","unstructured":"Hong X, Jiang S, Marmolejo N et al (2018) Serum vascular endothelial growth factor receptor 3 as a potential biomarker in psoriasis. Exp Dermatol 27:1053\u20131057","journal-title":"Exp Dermatol"},{"key":"7138_CR18","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jaad.2020.10.094","volume":"84","author":"YA Elnabawi","year":"2021","unstructured":"Elnabawi YA, Garshick MS, Tawil M et al (2021) CCL20 in psoriasis: A potential biomarker of disease severity, inflammation, and impaired vascular health. J Am Acad Dermatol 84:913\u2013920","journal-title":"J Am Acad Dermatol"},{"key":"7138_CR19","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/1346-8138.16032","volume":"48","author":"Y Matsunaga","year":"2021","unstructured":"Matsunaga Y, Hashimoto Y, Ishiko A (2021) Stratum corneum levels of calprotectin proteins S100A8\/A9 correlate with disease activity in psoriasis patients. J Dermatol 48:1518\u20131525","journal-title":"J Dermatol"},{"key":"7138_CR20","doi-asserted-by":"publisher","first-page":"7420823","DOI":"10.1155\/2020\/7420823","volume":"2020","author":"A Michalak-Stoma","year":"2020","unstructured":"Michalak-Stoma A, Bartosinska J, Kowal M et al (2020) IL-17A in the psoriatic patients\u2019 serum and plaque scales as potential marker of the diseases severity and obesity. Mediators Inflamm 2020:7420823","journal-title":"Mediators Inflamm"},{"issue":"2455\u20132463","key":"7138_CR21","volume":"142","author":"BR Mok","year":"2022","unstructured":"Mok BR, Kim AR, Baek SH et al (2022) PFN1 prevents psoriasis pathogenesis through IkappaBzeta regulation. J Invest Dermatol 142(2455\u20132463):e2459","journal-title":"J Invest Dermatol"},{"key":"7138_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000488672","volume":"234","author":"Z Sun","year":"2018","unstructured":"Sun Z, Shi X, Wang Y et al (2018) Serum squamous cell carcinoma antigen in psoriasis: a potential quantitative biomarker for disease severity. Dermatology 234:120\u2013126","journal-title":"Dermatology"},{"key":"7138_CR23","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.2147\/JIR.S378953","volume":"15","author":"X Sun","year":"2022","unstructured":"Sun X, Liu L, Chen S et al (2022) Fibrinogen-like protein 1 as a novel biomarker of psoriasis severity. J Inflamm Res 15:4637\u20134647","journal-title":"J Inflamm Res"},{"key":"7138_CR24","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.jid.2019.08.457","volume":"140","author":"MT Sanz-Martinez","year":"2020","unstructured":"Sanz-Martinez MT, Moga E, Sanchez Martinez MA et al (2020) High levels of platelet-lymphocyte complexes in patients with psoriasis are associated with a better response to anti-TNF-alpha therapy. J Invest Dermatol 140:1176\u20131183","journal-title":"J Invest Dermatol"},{"key":"7138_CR25","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/1346-8138.14308","volume":"45","author":"T Shibuya","year":"2018","unstructured":"Shibuya T, Honma M, Iinuma S et al (2018) Alteration of serum thymus and activation-regulated chemokine level during biologic therapy for psoriasis: possibility as a marker reflecting favorable response to anti-interleukin-17A agents. J Dermatol 45:710\u2013714","journal-title":"J Dermatol"},{"key":"7138_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jdermsci.2017.01.008","volume":"86","author":"H Nakajima","year":"2017","unstructured":"Nakajima H, Serada S, Fujimoto M et al (2017) Leucine-rich alpha-2 glycoprotein is an innovative biomarker for psoriasis. J Dermatol Sci 86:170\u2013174","journal-title":"J Dermatol Sci"},{"key":"7138_CR27","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1600-0625.2010.01095.x","volume":"19","author":"J Garbaraviciene","year":"2010","unstructured":"Garbaraviciene J, Diehl S, Varwig D et al (2010) Platelet P-selectin reflects a state of cutaneous inflammation: possible application to monitor treatment efficacy in psoriasis. Exp Dermatol 19:736\u2013741","journal-title":"Exp Dermatol"},{"key":"7138_CR28","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.7150\/thno.31144","volume":"9","author":"M Xu","year":"2019","unstructured":"Xu M, Deng J, Xu K et al (2019) In-depth serum proteomics reveals biomarkers of psoriasis severity and response to traditional Chinese medicine. Theranostics 9:2475\u20132488","journal-title":"Theranostics"},{"issue":"52","key":"7138_CR29","first-page":"667","volume":"2019","author":"Committee on Psoriasis, C. S. o. D.","year":"2018","unstructured":"Committee on Psoriasis, C. S. o. D. (2019) Guideline for the diagnosis and treatment of psoriasis in China, (2018) complete edition). Chinese Journal of Dermatology (52):667\u2013710","journal-title":"Chinese Journal of Dermatology"},{"key":"7138_CR30","doi-asserted-by":"crossref","unstructured":"Deng J, Yao D, Lu C et al. (2017) Oral Chinese herbal medicine for psoriasis vulgaris: protocol for a randomised, double-blind, double-dummy, multicentre clinical trial 7, e014475","DOI":"10.1136\/bmjopen-2016-014475"},{"key":"7138_CR31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/1745-6215-15-294","volume":"15","author":"ZH Wen","year":"2014","unstructured":"Wen ZH, Xuan ML, Yan YH et al (2014) Chinese medicine combined with calcipotriol betamethasone and calcipotriol ointment for Psoriasis vulgaris (CMCBCOP): study protocol for a randomized controlled trial. Trials 15:294","journal-title":"Trials"},{"key":"7138_CR32","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665\u20132673","journal-title":"Arthritis Rheum"},{"key":"7138_CR33","unstructured":"Centre for Urticaria Research, C. S. o. D. (2022) Guideline for diagnosis and treatment of urticaria in China (2022). Chinese Journal of Dermatology 12, 1041 -1049"},{"key":"7138_CR34","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000083509","volume":"210","author":"J Schmitt","year":"2005","unstructured":"Schmitt J, Wozel G (2005) The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology 210:194\u2013199","journal-title":"Dermatology"},{"key":"7138_CR35","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1684\/ejd.2013.1931","volume":"23","author":"JW Choi","year":"2013","unstructured":"Choi JW, Kwon SH, Youn JI et al (2013) Objective measurements of erythema, elasticity and scale could overcome the inter- and intra-observer variations of subjective evaluations for psoriasis severity. Eur J Dermatol 23:224\u2013229","journal-title":"Eur J Dermatol"},{"issue":"Suppl 2","key":"7138_CR36","first-page":"S1","volume":"10","author":"A Nast","year":"2012","unstructured":"Nast A, Boehncke WH, Mrowietz U et al (2012) S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update J Dtsch Dermatol Ges 10(Suppl 2):S1-95","journal-title":"Update J Dtsch Dermatol Ges"},{"key":"7138_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jdermsci.2023.07.005","volume":"111","author":"J Deng","year":"2023","unstructured":"Deng J, Leijten E, Zhu Y et al (2023) Multi-omics approach identifies PI3 as a biomarker for disease severity and hyper-keratinization in psoriasis. J Dermatol Sci 111:101\u2013108","journal-title":"J Dermatol Sci"},{"key":"7138_CR38","doi-asserted-by":"crossref","unstructured":"Fouda I, Alghonemy SM, Obaid Z et al.(2020) Assessment of serum elafin as a possible inflammatory marker in psoriasis. Al-Azhar Assiut Medical Journal 18","DOI":"10.4103\/AZMJ.AZMJ_86_20"},{"key":"7138_CR39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/1523-1747.ep12391802","volume":"103","author":"K Nonomura","year":"1994","unstructured":"Nonomura K, Yamanishi K, Yasuno H et al (1994) Up-regulation of elafin\/SKALP gene expression in psoriatic epidermis. J Invest Dermatol 103:88\u201391","journal-title":"J Invest Dermatol"},{"key":"7138_CR40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1046\/j.1523-1747.2002.01803.x","volume":"119","author":"H Nakane","year":"2002","unstructured":"Nakane H, Ishida-Yamamoto A, Takahashi H et al (2002) Elafin, a secretory protein, is cross-linked into the cornified cell envelopes from the inside of psoriatic keratinocytes. J Invest Dermatol 119:50\u201355","journal-title":"J Invest Dermatol"},{"key":"7138_CR41","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1067\/mai.2000.105706","volume":"105","author":"M Greaves","year":"2000","unstructured":"Greaves M (2000) Chronic urticaria. J Allergy Clin Immunol 105:664\u2013672","journal-title":"J Allergy Clin Immunol"},{"key":"7138_CR42","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.it.2009.07.008","volume":"30","author":"H Valdimarsson","year":"2009","unstructured":"Valdimarsson H, Thorleifsdottir RH, Sigurdardottir SL et al (2009) Psoriasis\u2013as an autoimmune disease caused by molecular mimicry. Trends Immunol 30:494\u2013501","journal-title":"Trends Immunol"},{"key":"7138_CR43","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/gene.2014.75","volume":"16","author":"J Nititham","year":"2015","unstructured":"Nititham J, Taylor KE, Gupta R et al (2015) Meta-analysis of the TNFAIP3 region in psoriasis reveals a risk haplotype that is distinct from other autoimmune diseases. Genes Immun 16:120\u2013126","journal-title":"Genes Immun"},{"key":"7138_CR44","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic arthritis. N Engl J Med 376:957\u2013970","journal-title":"N Engl J Med"},{"key":"7138_CR45","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jaad.2018.06.026","volume":"79","author":"HJ Ju","year":"2018","unstructured":"Ju HJ, Kim KJ, Kim DS et al (2018) Increased risks of autoimmune rheumatic diseases in patients with psoriasis: a nationwide population-based study. J Am Acad Dermatol 79:778\u2013781","journal-title":"J Am Acad Dermatol"},{"key":"7138_CR46","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jaad.2012.04.039","volume":"67","author":"JJ Wu","year":"2012","unstructured":"Wu JJ, Nguyen TU, Poon KY et al (2012) The association of psoriasis with autoimmune diseases. J Am Acad Dermatol 67:924\u2013930","journal-title":"J Am Acad Dermatol"},{"key":"7138_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/1523-1747.ep12612749","volume":"104","author":"HA Alkemade","year":"1995","unstructured":"Alkemade HA, de Jongh GJ, Arnold WP et al (1995) Levels of skin-derived antileukoproteinase (SKALP)\/elafin in serum correlate with disease activity during treatment of severe psoriasis with cyclosporin A. J Invest Dermatol 104:189\u2013193","journal-title":"J Invest Dermatol"},{"key":"7138_CR48","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1124\/pr.110.002733","volume":"62","author":"B Korkmaz","year":"2010","unstructured":"Korkmaz B, Horwitz MS, Jenne DE et al (2010) Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev 62:726\u2013759","journal-title":"Pharmacol Rev"},{"key":"7138_CR49","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1083\/jcb.201006052","volume":"191","author":"V Papayannopoulos","year":"2010","unstructured":"Papayannopoulos V, Metzler KD, Hakkim A et al (2010) Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol 191:677\u2013691","journal-title":"J Cell Biol"},{"key":"7138_CR50","doi-asserted-by":"publisher","first-page":"490","DOI":"10.4049\/jimmunol.1100123","volume":"187","author":"AM Lin","year":"2011","unstructured":"Lin AM, Rubin CJ, Khandpur R et al (2011) Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 187:490\u2013500","journal-title":"J Immunol"},{"key":"7138_CR51","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1111\/jdv.13650","volume":"30","author":"J Muto","year":"2016","unstructured":"Muto J, Fujimoto N, Ono K et al (2016) Deposition of elafin in the involved vascular wall of neutrophil-mediated cutaneous vasculitis. J Eur Acad Dermatol Venereol 30:1544\u20131549","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"7138_CR52","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2340\/0001555580106110","volume":"80","author":"N Tanaka","year":"2000","unstructured":"Tanaka N, Fujioka A, Tajima S et al (2000) Levels of proelafin peptides in the sera of the patients with generalized pustular psoriasis and pustulosis palmoplantaris. Acta Derm Venereol 80:102\u2013105","journal-title":"Acta Derm Venereol"},{"key":"7138_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/00071668.2019.1686124","volume":"61","author":"JH Lee","year":"2020","unstructured":"Lee JH, Moon SH, Hong Y et al (2020) Anti-elastase and anti-hyaluronidase activity of phosvitin isolated from hen egg yolk. Br Poult Sci 61:17\u201321","journal-title":"Br Poult Sci"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07138-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07138-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07138-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T05:06:01Z","timestamp":1729227961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07138-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["7138"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07138-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,17]]},"assertion":[{"value":"25 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was approved by the ethical committees at the Guangdong\u00a0Provincial Hospital of Chinese Medicine (B2012-53-01). Informed consent was\u00a0obtained from all subjects and\/or their legal guardian(s). All methods were\u00a0carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the manuscript for submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}